Precigen (PGEN) Total Current Liabilities (2012 - 2026)

Precigen's (PGEN) quarterly Total Current Liabilities came in at $21.1 million in Q1 2026, down 12.02% year-on-year from $24.0 million in Q1 2025, and down 43.43% on a QoQ basis from $37.3 million in Q4 2025.

Precigen (PGEN) Total Current Liabilities (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Total Current Liabilities data on file, last reported at $21.1 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 12.02% year-over-year to $21.1 million in Q1 2026; TTM through Mar 2026 was $21.1 million, a 12.02% decrease from a year earlier, with the FY2025 full-year figure at $37.3 million, up 73.37% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $21.1 million, down from $37.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PGEN reached as high as $104.9 million in Q3 2022 and fell as low as $21.1 million in Q1 2026.
  • Historically, Total Current Liabilities has averaged $35.6 million across 5 years, with a median of $28.8 million in 2024.
  • Across the five-year window, Total Current Liabilities surged 261.74% in 2022 and sank 70.77% in 2023, its largest moves.
  • Year by year, Total Current Liabilities stood at $78.6 million in 2022, then sank by 70.77% to $23.0 million in 2023, then dropped by 6.38% to $21.5 million in 2024, then jumped by 73.37% to $37.3 million in 2025, then tumbled by 43.43% to $21.1 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $21.1 million in Q1 2026, $37.3 million in Q4 2025, and $32.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 21.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.10 Mn
Dec 31, 2025 37.31 Mn
Sep 30, 2025 32.07 Mn
Jun 30, 2025 23.19 Mn
Mar 31, 2025 23.99 Mn
Dec 31, 2024 21.52 Mn
Sep 30, 2024 21.22 Mn
Jun 30, 2024 23.02 Mn
Mar 31, 2024 28.77 Mn
Dec 31, 2023 22.99 Mn
Sep 30, 2023 32.88 Mn
Jun 30, 2023 30.77 Mn
Mar 31, 2023 46.73 Mn
Dec 31, 2022 78.65 Mn
Sep 30, 2022 104.86 Mn
Jun 30, 2022 29.90 Mn
Mar 31, 2022 25.60 Mn
Dec 31, 2021 34.65 Mn
Sep 30, 2021 28.99 Mn
Jun 30, 2021 28.87 Mn